InvestorsHub Logo
Followers 48
Posts 4547
Boards Moderated 0
Alias Born 10/26/2016

Re: None

Sunday, 10/08/2017 11:27:42 PM

Sunday, October 08, 2017 11:27:42 PM

Post# of 1237
New on this and was hoping that someone (longs) can give some insight.

This seems to be a good potential for a stock to go long - but I have some questions..Hopefully someone can shed some light.

1. From recent news, the company indicated that the recent stock issuance is to allow the Company to fund the "initiation of its Phase 3 clinical program" of RP-G28 for the treatment of lactose intolerance, expected to begin in the first half of 2018. --->The word "initiation" somehow really bothers me as it sounds like, there may be more coming. Can someone shed somelight on this?

2. Potential of >$1.2Billions of prescription market. Can someone translate tha to sales or perhaps potential sp?

3. Timeline of completion of P3 Trial?

Thanks